S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
ASX:FCL

FINEOS (FCL) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
FCL stock logo

About FINEOS Stock (ASX:FCL)

FINEOS Corporation Holdings plc, together with its subsidiaries, engages in the development and sale of enterprise claims and policy management software for employee benefits and life, accident, and health insurance industries worldwide. The company offers FINEOS Platform, a Software-as-a-Service core insurance platform. Its FINEOS Platform comprises FINEOS AdminSuite, a comprehensive core insurance suite; FINEOS Engage, which makes connections across customers and partners to create frictionless engagement and agile business relationships; and FINEOS Insight that allows insurers to use customer-centric data models to gain real-time analytics data. The company also provides insurance underwriting solutions, and absence management solutions, as well as integrated disability and absence management solutions. In addition, it offers professional and customer support services, product consulting, training and education, marketing, and product engineering services. The company was founded in 1993 and is headquartered in Dublin, Ireland. FINEOS Corporation Holdings plc operates as a subsidiary of Jacquel Investments Limited.

FCL Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Can this ASX tech stock keep rallying?
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
New Ireland Becomes Newest FINEOS Client
Fineotex Chemical Limited (FCL.NS)
FINEOS Corporation Holdings PLC
See More Headlines
Receive FCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FINEOS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Software - Infrastructure
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,042
Year Founded
N/A

Profitability

Net Income
$-21,420,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$125.04 million
Book Value
A$0.46 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.25
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Michael Kelly
    Founder, CEO & Executive Director
  • Mr. Ian Lynagh
    Chief Financial Officer
  • Mr. John Brennan
    Chief Operating Officer
  • Mr. Jonathan Boylan
    Chief Technology Officer
  • Niall Hannon
    Head of Information Systems
  • Orla Keegan
    Head of Investor Relations
  • Ms. Paula McGrath
    Security & Compliance Manager
  • Mr. Chuck Johnston
    Chief Marketing Officer
  • Ms. Joanne McMullan
    Chief People Officer
  • Mr. David Nicolai
    Senior Vice President of Sales - North America

This page (ASX:FCL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners